Lundbeck
HLUN-B.CO
#2510
Rank
A$8.93 B
Marketcap
$9.34
Share price
-0.93%
Change (1 day)
17.83%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total debt

Total debt on the balance sheet as of June 2024 : A$0.90 Billion

According to Lundbeck 's latest financial reports the company's total debt is A$0.90 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Lundbeck - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$0.90 B-23.57%
2022-12-31A$1.18 B5.64%
2021-12-31A$1.11 B-34.11%
2020-12-31A$1.69 B-17.31%
2019-12-31A$2.05 B
2018-12-31N/A-100%
2017-12-31A$11.77 M-96.84%
2016-12-31A$0.37 B-50.89%
2015-12-31A$0.75 B13.67%
2014-12-31A$0.66 B48.81%
2013-12-31A$0.44 B37.64%
2012-12-31A$0.32 B-0.15%
2011-12-31A$0.32 B-3.8%
2010-12-31A$0.33 B-54.5%
2009-12-31A$0.74 B47.05%
2008-12-31A$0.50 B21.48%
2007-12-31A$0.41 B29.44%
2006-12-31A$0.32 B287.98%
2005-12-31A$83.07 M-13.93%
2004-12-31A$96.52 M